Research Center: ACRC Trials
Location: 5625 Eiger Rd, Suite 200, Austin, TX 78735
Lead Researcher: Matthew Brimberry, M.D.
IRB Committee: This study has been reviewed and approved by the Advarra Institutional Review Board

About the Study

Acute cystitis, otherwise known as uncomplicated urinary tract infection (UTI), is common among women. About 11% of women above 18 years old have had at least 1 episode of UTI each year. There are times that women who have frequent UTIs suffer from antibiotic resistance and they would need new and stronger medications. 

Researchers at ACRC Trials are conducting a research study open to women who have UTI and are not currently pregnant. This research study is looking into a new antibiotic that could help treat UTIs that may be resistant to other older antibiotics. This study may help individuals have access to a new treatment that could potentially help better treat their symptoms. 

Why Participate? 

• Participants will receive a new potential treatment for UTI at no cost.
• Participants will receive all study-related care from a local doctor at no cost.
• Participants may experience improvements with UTI. 
• Participants will be contributing valuable information that may benefit those with UTI in the future.
• Participants will be reimbursed for all study-related travel expenses.
• Participants will be helping to advance women’s health research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time.
• Any information that you provide will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Women aged 12 years old and up 
• Must be experiencing UTI symptoms for 3 days or less
• Must not be pregnant
• Must be able to attend 4 study visits at the research site over across approximately 28 days

Participants below 18 years old will require parental or legal guardian consent to join in this study.

Key Study Details 
The study team will explain the research study in its entirety but some details are:

• Most of the study visits will require about 2-4 hours to complete.
• Participation in this study will include taking the study medication twice a day for 5 days. 
• The study medication will be in a pill form (i.e., tablet or capsule).

About the Research Center:

ACRC TRIALS

ACRC Trials is an investigator site network of award-winning physician practices and clinics, specializing in Phase II-IV pharmaceutical and device studies. With an emphasis on excellence, reliability, and volunteer care, ACRC Trials is committed to upholding the highest standards of quality in implementing clinical research studies and managing volunteer safety.

Please note:
Due to the COVID-19 pandemic, the researchers would like to assure the participants that ensuring their and the study staff’s safety is of utmost importance.